Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
June 1, 2024Journal of Clinical Oncology

A phase 1, multi-center, open-label, dose-escalation, and dose-expansion study of CBP-1018, a bi-ligand-drug conjugate in patients with heavily treated advanced solid tumors.

View Full Paper
Ask AI
Bookmark
Share

Authors

KLKaiwen LiJWJunyan WuSYSuiwen Ye

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e67065b6db6435875faf50https://doi.org/10.1200/jco.2024.42.16_suppl.5047
View Full Paper
Ask AI
Bookmark
Share